/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

M

Maarten C.C.M. Hulshof

Amsterdam University Medical Centers(NL)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

400

Papers

19.6K

Citations

51

h-index

172

i10-index

Maarten C.C.M. Hulshof is an academic researcher from Amsterdam University Medical Centers. The author has contributed to research in topics: Esophageal Cancer Research and Treatment & Gastric Cancer Management and Outcomes & Lung Cancer Diagnosis and Treatment. The author has an h-index of 51, co-authored 340 publications.

ORCID: 0000-0001-5240-3467

Research Topics

Esophageal Cancer Research and Treatment Gastric Cancer Management and Outcomes Lung Cancer Diagnosis and Treatment Esophageal and GI Pathology Advanced Radiotherapy Techniques

Papers by this author

works

Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial

2021 · Journal of Clinical Oncology · 732 citations

https://doi.org/10.1200/jco.20.03614

Ben M. Eyck J. Jan B. van Lanschot Maarten C.C.M. Hulshof Berend J. van der Wilk

Patterns of Recurrence After Surgery Alone Versus Preoperative Chemoradiotherapy and Surgery in the CROSS Trials

2014 · Journal of Clinical Oncology · 499 citations

https://doi.org/10.1200/jco.2013.51.2186

Vera Oppedijk Ate van der Gaast J. Jan B. van Lanschot Pieter van Hagen

Nationwide comprehensive gastro-intestinal cancer cohorts: the 3P initiative

2017 · Acta Oncologica · 81 citations

https://doi.org/10.1080/0284186x.2017.1346381

Robert R.J. Coebergh van den Braak L. Bengt van Rijssen Jessy Joy van Kleef Geraldine R. Vink

Impact of neoadjuvant chemoradiotherapy on health-related quality of life in long-term survivors of esophageal or junctional cancer: results from the randomized CROSS trial

2017 · Annals of Oncology · 81 citations

https://doi.org/10.1093/annonc/mdx726

Bo Jan Noordman Mathilde G. E. Verdam Sjoerd M. Lagarde Joël Shapiro

Phase II Feasibility and Biomarker Study of Neoadjuvant Trastuzumab and Pertuzumab With Chemoradiotherapy for Resectable Human Epidermal Growth Factor Receptor 2–Positive Esophageal Adenocarcinoma: TRAP Study

2019 · Journal of Clinical Oncology · 72 citations

https://doi.org/10.1200/jco.19.01814

Charlotte I. Stroes Sandor Schokker Aafke Creemers Remco J. Molenaar

Preoperative image-guided identification of response to neoadjuvant chemoradiotherapy in esophageal cancer (PRIDE): a multicenter observational study

2018 · BMC Cancer · 64 citations

https://doi.org/10.1186/s12885-018-4892-6

Alicia S. Borggreve S. Mook Marcel Verheij Véronique E. Mul

Research topics

topics

Esophageal Cancer Research and Treatment

Gastric Cancer Management and Outcomes

Lung Cancer Diagnosis and Treatment

Esophageal and GI Pathology

Advanced Radiotherapy Techniques

Chat about Author

Papers

Chat

Click to start Chat